SciTransfer
Organization

KOPPERT BV

Dutch biocontrol company breeding natural enemies and microbial agents to replace pesticides in commercial agriculture.

Large industrial companyfoodNLNo active H2020 projects
H2020 projects
2
As coordinator
0
Total EC funding
€511K
Unique partners
22
What they do

Their core work

Koppert BV is a Dutch private company and global leader in biological crop protection, specializing in the development, production, and deployment of natural enemies — predatory insects, mites, and beneficial microorganisms — to replace or reduce chemical pesticides in commercial agriculture. Their core expertise lies in biocontrol product development, where they breed and optimize natural enemy populations for use against a wide range of agricultural pests. In EU research projects, they serve as an industry partner providing practical knowledge, biological material, and real-world field conditions for training and applied research. Their participation in MSCA training networks suggests they also invest in developing the next generation of biocontrol scientists by hosting early-stage researchers.

Core expertise

What they specialise in

Biological pest control (biocontrol)primary
2 projects

Both BINGO and MIRA directly concern biocontrol methods — breeding natural enemies and microbe-induced resistance — reflecting Koppert's core commercial activity.

Breeding and genetic improvement of beneficial invertebratesprimary
1 project

BINGO (2015–2018) focused specifically on population genomics, genetic markers, and genetic improvement of natural enemies for next-generation biocontrol products.

Microbe-induced plant resistancesecondary
1 project

MIRA (2017–2021) explored how microorganisms can be used to trigger plant resistance against agricultural pests, broadening Koppert's approach beyond direct predator deployment.

Sustainable agriculture and IPM (Integrated Pest Management)secondary
2 projects

Sustainable agriculture and pest management appear as consistent keywords across BINGO, indicating Koppert frames its work within the reduction of chemical inputs in food production.

Population genomics and risk monitoring of natural enemiessecondary
1 project

BINGO lists population genomics, genetic markers, and risk and monitoring as keywords, pointing to Koppert's interest in understanding and managing genetic diversity in their biocontrol agents.

Evolution & trajectory

How they've shifted over time

Early focus
Invertebrate breeding and population genomics
Recent focus
Microbe-induced plant resistance

Koppert's earliest H2020 engagement (BINGO, 2015–2018) was firmly grounded in the genetics and life history of natural enemies — understanding how to breed, select, and monitor invertebrate biocontrol agents at a population level. Their second project (MIRA, 2017–2021) shifted the lens from the predator to the plant, investigating how microbial agents can induce resistance in crops directly. This suggests a deliberate broadening of their biocontrol toolkit: from "deploy natural enemies" toward "make plants more resistant through microbes," which is a distinct and complementary mode of action. With only two projects and no keywords recorded for MIRA, the direction after 2021 cannot be confirmed from this dataset alone.

Koppert appears to be expanding from breeding-based biocontrol into microbiome-driven plant protection, suggesting future collaborations may span both entomology and microbial ecology.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European12 countries collaborated

Koppert has participated exclusively as a consortium partner — never as coordinator — in both their H2020 projects, both of which were MSCA Initial Training Networks. This is a typical industry-partner role in MSCA-ITN consortia: providing secondment placements and applied research environments for doctoral candidates rather than leading scientific direction. Their 22 unique partners across 12 countries from just 2 projects indicates they joined well-connected, multi-institutional training networks rather than small bilateral arrangements.

Koppert has built connections with 22 distinct consortium partners spanning 12 countries through only 2 projects, reflecting the broad multi-institutional composition typical of MSCA training networks. Their network is European in reach, likely including academic institutions and research institutes across Northern and Western Europe given the agricultural focus.

Why partner with them

What sets them apart

Koppert BV is unusual in the H2020 landscape as a large private company (non-SME) in biological crop protection — a sector where most industry participants are either SMEs or agrochemical giants. Their participation in MSCA training networks specifically signals a commitment to long-term talent development and academic collaboration rather than pure product commercialization. For a consortium building a project at the intersection of sustainable agriculture, IPM, and biological science, Koppert offers direct access to commercial-scale biocontrol knowledge, real production pipelines, and an established global distribution network for biological agents.

Notable projects

Highlights from their portfolio

  • BINGO
    Represents Koppert's most keyword-rich and technically detailed H2020 engagement, combining population genomics, genetic improvement, and risk monitoring to advance the science of breeding better biocontrol agents.
  • MIRA
    Marks a conceptual expansion into microbe-induced resistance — a different mode of action from Koppert's core predator-deployment business — suggesting deliberate investment in next-generation plant protection strategies.
Cross-sector capabilities
environment — biodiversity and ecosystem services linked to natural enemy populationshealth — microbiome research applicable beyond agriculturemanufacturing — biological agent production and quality control at industrial scale
Analysis note: Only 2 projects, both MSCA-ITN (training networks where Koppert plays a supporting industry-partner role rather than leading research). Keywords for MIRA are absent, limiting evolution analysis. Profile is enriched by external knowledge of Koppert's well-documented commercial identity in biocontrol — but claims about their broader business are inferred from domain knowledge, not CORDIS data alone.